Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection (Q42947251)

11 November 2017

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection (English)

1 reference

11 November 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

16

Namiki Izumi

1 reference

11 November 2017

Yasuhiro Asahina

1

1 reference

11 November 2017

Kaoru Tsuchiya

2

1 reference

11 November 2017

Nobuharu Tamaki

3

1 reference

11 November 2017

Itsuko Hirayama

4

1 reference

11 November 2017

Tomohiro Tanaka

5

1 reference

11 November 2017

Mitsuaki Sato

6

1 reference

11 November 2017

Yutaka Yasui

7

1 reference

11 November 2017

Takanori Hosokawa

8

1 reference

11 November 2017

Ken Ueda

9

1 reference

11 November 2017

Teiji Kuzuya

10

1 reference

11 November 2017

Hiroyuki Nakanishi

11

1 reference

11 November 2017

Jun Itakura

12

1 reference

11 November 2017

Yuka Takahashi

13

1 reference

11 November 2017

Masayuki Kurosaki

14

1 reference

11 November 2017

Nobuyuki Enomoto

15

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

11 November 2017

1 reference

11 November 2017

52

1 reference

11 November 2017

518-527

1 reference

11 November 2017

2

1 reference

Global cancer statistics in the year 2000.

11 November 2017

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

21 January 2018

1 reference

Population aging and cancer: a cross-national concern.

21 January 2018

1 reference

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

21 January 2018

1 reference

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

21 January 2018

1 reference

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.

21 January 2018

1 reference

Impact of aging on the development of hepatocellular carcinoma in patients with hepatitis C virus infection in Japan

21 January 2018

1 reference

Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

21 January 2018

1 reference

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.

21 January 2018

1 reference

Animal models for hepatitis C and related liver disease

21 January 2018

1 reference

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

21 January 2018

1 reference

Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.

21 January 2018

1 reference

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

21 January 2018

1 reference

Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.

21 January 2018

1 reference

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

21 January 2018

1 reference

Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status

21 January 2018

1 reference

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

21 January 2018

1 reference

Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan

21 January 2018

1 reference

Hepatitis C and hepatocellular carcinoma

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.23691

1 reference

11 November 2017

1 reference